|
US 6,982,262 B2 |
|
Combination of cyamemazine and an atypical neuroleptic |
Michel Dib, Paris (France); and Cyrille Leperlier, Fontainebleau (France) |
Assigned to Aventis Pharma S. A., Antony (France) |
Filed on Feb. 20, 2004, as Appl. No. 10/783,451. |
Application 10/783451 is a continuation of application No. 10/164771, filed on Jun. 07, 2002, granted, now 6,720,318. |
Application 10/164771 is a continuation of application No. PCT/FR00/03446, filed on Dec. 08, 2000, abandoned. |
Claims priority of application No. 99 15632 (FR), filed on Dec. 10, 1999. |
Prior Publication US 2004/0167125 A1, Aug. 26, 2004 |
This patent is subject to a terminal disclaimer. |
Int. Cl. A61K 31/5415 (2006.01); A61K 31/496 (2006.01); A61K 31/454 (2006.01)
|